Options Brief: Savient Pharmaceuticals

Shares of Savient Pharmaceuticals SVNT are lower on the session by 1.96%, trading at $6.49. Overall put volume is now running at 6.24x the daily average, with 89% of all puts traded being purchases on the offer. 1,161 contracts have traded on the session so far. Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on commercializing KRYSTEXXA in the United States and completing the development and seeking regulatory approval outside of the United States for KRYSTEXXA.